- Home
- DOV vs BNTX Comparison
DOV vs BNTX Comparison
Compare DOV & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOV
- BNTX
- Stock Information
- Founded
- DOV 1947
- BNTX 2008
- Country
- DOV United States
- BNTX Germany
- Employees
- DOV N/A
- BNTX N/A
- Industry
- DOV Industrial Machinery/Components
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DOV Industrials
- BNTX Health Care
- Exchange
- DOV Nasdaq
- BNTX Nasdaq
- Market Cap
- DOV 27.6B
- BNTX 23.9B
- IPO Year
- DOV N/A
- BNTX 2019
- Fundamental
- Price
- DOV $191.24
- BNTX $114.00
- Analyst Decision
- DOV Buy
- BNTX Strong Buy
- Analyst Count
- DOV 12
- BNTX 15
- Target Price
- DOV $212.83
- BNTX $143.50
- AVG Volume (30 Days)
- DOV 677.8K
- BNTX 659.5K
- Earning Date
- DOV 01-30-2025
- BNTX 11-04-2024
- Dividend Yield
- DOV 1.09%
- BNTX N/A
- EPS Growth
- DOV 53.59
- BNTX N/A
- EPS
- DOV 11.19
- BNTX N/A
- Revenue
- DOV $8,474,513,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- DOV N/A
- BNTX N/A
- Revenue Next Year
- DOV $5.13
- BNTX N/A
- P/E Ratio
- DOV $17.29
- BNTX N/A
- Revenue Growth
- DOV 7.02
- BNTX N/A
- 52 Week Low
- DOV $143.97
- BNTX $76.53
- 52 Week High
- DOV $208.26
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- DOV 31.86
- BNTX 48.71
- Support Level
- DOV $186.96
- BNTX $109.52
- Resistance Level
- DOV $190.53
- BNTX $115.34
- Average True Range (ATR)
- DOV 3.06
- BNTX 4.24
- MACD
- DOV -1.48
- BNTX -0.72
- Stochastic Oscillator
- DOV 19.04
- BNTX 27.24
About DOV Dover Corporation
Dover Corp is a diversified manufacturer and solutions provider delivering equipment and components, consumable supplies, aftermarket parts, software digital solutions, and support services. It operates through five segments: engineered systems, clean energy, and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.